Is there a benefit of low-dose aspirin in assisted reproduction?

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 3, 2006, Pages 313-318

  Daya, Salim ^a  

^a ISIS Regional Fertility Centre   (Canada)

Author keywords

Aspirin; Assisted reproduction; Congenital anomalies; Infertility; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

BEHAVIOR DISORDER; BIRTH RATE; BLEEDING; CLINICAL TRIAL; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFERTILITY; INFERTILITY THERAPY; MEDICAL DECISION MAKING; META ANALYSIS; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ASPIRIN; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; RESEARCH DESIGN; UTERUS;

EID: 33745006140     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000193013.19147.9a     Document Type: Review

References (20)

1. Goswamy RK, Steptoe PC. Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Hum Reprod 1988; 3:721-726.
2. Battaglia C, Larocca E, Lanzani A, et al. Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. Gynecol Endocrinol 1990; 4:245-250.
3. Steer CV, Mills C, Campbell C, et al. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57:372-376.
4. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherosclerosis. N Engl J Med 2005; 353:2373-2383. This study contains excellent sections on pharmacokinetics and mechanism of action of aspirin.
5. Pedersen AK, FitzGerald GA. Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984; 311:1206-1211.
6. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69:1366-1372.
7. Bussolino F, Bendetto C, Massobrio M, Camussi G. Maternal vascular prostacyclin activity in preeclampsia. Lancet 1980; ii:702.
8. Daya S, Gunby J. Recombinant compared with urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999; 14:2207-2215.
9. Daya S. Intention-to-treat analysis: a necessity for clinical trials. Evidence-based Obstet Gynecol 2003; 5:1-3.
10. Daya S. Pitfalls in the design and analysis of efficacy trials in subfertility. Hum Reprod 2003; 18:1005-1009.
11. Daya S. The blindness of blinding in clinical trials. Evidence-based Obstet Gynecol 2004; 6:45-47.
12. Rubinstein LN, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999; 71:825-829.
13. Urman B, Mercan R, Alatas C, et al. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet 2000; 17:586-590.
14. Hurst BS, Bhojwani JT, Marshburn PB, et al. Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. J Exp Clin Assisted Reprod 2005; 2:8 (10.1186/1743-1050-2- 8).
15. Pakkila M, Rasanen J, Heionen S, et al. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Hum Reprod 2005; 20:2211-2214. A well conducted trial with high methodological quality.
16. Daya S. Aspirin and other adjuvants in assisted reproduction. In: Ben-Rafael Z, Creatsas G, Shoham Z, editors. Controversies in obstetrics and gynecology and infertility. Israel: Oren Publisher Ltd; 2005. pp. 272-283.
17. Daya S. Recurrent spontaneous early pregnancy loss and low dose aspirin. Minerva Gynecol 2003; 55:441-449.
18. Serebruany VL, Steinhubl SR, Berger PB, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol 2005; 95:1218-1222.
19. Kozer E, Nikfar S, Costei A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002; 187:1623-1630.
20. Hertz-Picciotto I, Hopenhayn-Rich C, Golub M, Hoper K. The risks and benefits of taking aspirin during pregnancy. Epidemiol Rev 1990; 12:108-148.